首页 | 本学科首页   官方微博 | 高级检索  
     


Facilitated reperfusion with prehospital glycoprotein IIb/IIIa inhibition: predictors of complete ST-segment resolution before primary percutaneous coronary intervention in the On-TIME 2 trial: Correlates of reperfusion before primary PCI
Authors:Ton Heestermans,Harry Suryapranata,Jurrië  n M. ten Berg,Arend Mosterd,A.T. Marcel Gosselink,Waclav Kochman,Thorsten Dill,Gert van Houwelingen,Evelien Kolkman,Jochem W. van Werkum,Felix Zijlstra,Christian Hamm,Arnoud W.J. van 't Hof
Affiliation:
  • a Department of Cardiology, Medisch Centrum Alkmaar, Alkmaar, The Netherlands
  • b Department of Cardiology, Isala Klinieken, Zwolle, The Netherlands
  • c Department of Cardiology, St Antonius Hospital, Nieuwegein, The Netherlands
  • d Department of Cardiology, Meander Medisch Centrum, Amersfoort, The Netherlands
  • e Department of Cardiology, University Medical Centre Utrecht, Utrecht, The Netherlands
  • f Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht, The Netherlands
  • g Department of Cardiology, Swissmed Centrum, Zdrowia S.A., Poland
  • h Department of Cardiology, Kerckhoff-Klinik GmbH, Bad Nauheim, Germany
  • i Department of Cardiology, Medisch Spectrum Twente, Enschede, The Netherlands
  • j Department of Medical Statistics, Diagram BV, Zwolle, The Netherlands
  • k Department of Cardiology, Universitair Medisch Centrum, Groningen, The Netherlands
  • Abstract:

    Objective

    The objective of this study is to evaluate the incidence, predictors, and outcome of complete ST-segment resolution (STR) during transportation after pretreatment with dual or triple antiplatelet therapy in the Ongoing Tirofiban in Myocardial Infarction Evaluation (On-TIME) 2 trial.

    Methods

    Patients with ST-segment elevation myocardial infarction were randomized in the ambulance to pretreatment with high-dose tirofiban (HDT) or to a control pretreatment (placebo or no HDT) on top of 600-mg clopidogrel, 500-mg aspirin, and 5000-IU unfractionated heparin. Complete STR was defined as ≥70% STR on the electrocardiogram obtained before percutaneous coronary intervention (PCI) as compared with the inclusion electrocardiogram.

    Results

    Complete STR before PCI occurred in 16.8% (n = 188/1121) and more frequently in the HDT group (19.0% vs 14.6%, P = .05). Independent predictors for complete STR before PCI were younger age (odds ratio [OR], 0.82; 95% confidence interval [CI], 0.70-0.96, P = .01 per 10 year increase), fast diagnosis (OR, 0.97; 95% CI, 0.97-1.0, P = .004 per 15-minute increase time from symptom onset to diagnosis), longer pretreatment time (OR, 1.09; 95% CI, 1.03-1.16, P = .003 per 15-minute increase time start study medication to angiography), and randomization to HDT (OR, 1.39; 95% CI, 1.0-1.9, P = .05). Complete STR before PCI was associated with very low 30-day (0.5% vs 2.8%, P = .07) and 1-year (1.1% vs 5.0%, P = .019) mortality.

    Conclusions

    Dual or triple antiplatelet pretreatment in the ambulance results in complete STR before PCI in 17% of patients. Fast ST-segment elevation myocardial infarction diagnosis, prehospital initiation of pretreatment early after symptom onset, and HDT independently predicted STR before PCI. Complete STR is associated with improved clinical outcome.
    Keywords:Reperfusion   Primary PCI   STEMI   Glycoprotein IIb/IIIa receptor inhibitors
    本文献已被 ScienceDirect 等数据库收录!
    设为首页 | 免责声明 | 关于勤云 | 加入收藏

    Copyright©北京勤云科技发展有限公司  京ICP备09084417号